Ideas & Insights

The IRS updated taxpayers on its operations status and recognized the delays in processing check payments due on July 15, 2020.

Applications to sell unused state net operating losses and state research and development credits available the week of May 1, 2020.

Here are some ways coronavirus could leave its mark on the global VAT, trade and tariff landscape for the life sciences industry.

Corporate taxpayers filing a consolidated return have an added layer of rules to navigate when carrying back a net operating loss.

The IRS provided long-awaited guidance for taxpayers anxious to take advantage of the NOL provisions in the CARES Act.

Recent guidance provides that certain deadlines, including the allowable time to invest in a QOF, are now extended because of COVID-19.

The IRS issued guidance extending the time for taxpayers to file certain Form 3115s and Form 1128s to July 15, 2020.

As businesses renegotiate debts in the aftermath of COVID-19, it is critical to understand whether the debt is considered publicly traded.

Accelerating worthless stock deductions on an insolvent subsidiary without disposing of the business to increase NOL carrybacks.

Delaware notices advise companies to either participate in the state’s unclaimed property VDA Program or be subject to an audit.

Department issued compliance alert explains the sales and use tax collection responsibilities for marketplace facilitators and sellers.

Three states have prescriptions for opioid taxes on manufacturers and distributors. Here’s what you need to know.

Notwithstanding unfavorable changes to the Code, capital gain treatment is still available on the sale of patents in certain scenarios.

Skepticism regarding artificial intelligence is understandable, but it’s often based on a misunderstanding of what AI really is.

Enhanced tax deduction may be available for drug inventory contributions made to certain charitable organizations.

The IRS is reconsidering the traditional rule requiring revenue to satisfy the active trade or business requirement of section 355.

Life sciences companies making payments to related foreign parties should be aware of how to determine the gross receipts calculation.

Missed our recent webcast on how the Tax Cuts and Jobs Act will affect life sciences companies? Check out our recap.

This recorded webcast provides an overview of the key provisions of the new tax bill and how they affect life sciences companies.

A review of IRS rulings on the proper treatment of similar expenses that were incurred by a pharmaceutical company.